Ocera Therapeutics, Pursuing New Drug for Liver, Hopes to Help People Stay Mentally Sharp
The liver is hot in the biotech world. Cambridge, MA-based Vertex Pharmaceuticals (NASDAQ: VRTX)
has made headlines this year with an antiviral drug that it hopes will do for hepatitis C—a
chronic liver-damaging condition affecting millions of people—what a previous generation of treatments did for HIV.
Read More >>>